MoonLake Immunotherapeutics Quarterly Operating Lease, Liability in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: MoonLake Immunotherapeutics quarterly Operating Lease, Liability history and growth rate from Q4 2021 to Q3 2024.
MoonLake Immunotherapeutics Operating Lease, Liability for the quarter ending September 30, 2024 was $3.38M, a 1895% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$3.38M	+$3.21M	+1895%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$3.34M	+$3.13M	+1483%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$3.66M	+$3.42M	+1387%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$3.7M	+$3.42M	+1209%	Dec 31, 2023	10-K	2024-02-29
Q3 2023	$169K			Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$211K			Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$246K			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$283K	-$152K	-35%	Dec 31, 2022	10-K	2023-03-20
Q4 2021	$435K			Jan 1, 2022	10-K	2023-03-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.